Covid-19 Therapeutic Alert: Colchicine in the Management of COVID-19 (SARS-CoV 2) Positive Patients - Trial Use Only, MHRA (published 12th February 2021)

Colchicine should NOT be used in the management of COVID-19 positive patients other than in the context of a trial, or unless there is an additional licensed indication for its use. Although early trial data is potentially promising, further evaluation of study data is needed.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news